Repligen Stock Today


USD 167.68  1.16  0.70%   

Market Performance
0 of 100
Odds Of Distress
Less than 1
Repligen is selling for 167.68 as of the 5th of July 2022. This is a 0.70 percent increase since the beginning of the trading day. The stock's open price was 166.52. Repligen has a very small chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. Equity ratings for Repligen Cp are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 10th of June 2021 and ending today, the 5th of July 2022. Click here to learn more.
Fiscal Year End
Business Domain
Pharmaceuticals, Biotechnology & Life Sciences
IPO Date
26th of March 1990
Health Care
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. Repligen Corporation was incorporated in 1981 and is headquartered in Waltham, Massachusetts. The company has 55.29 M outstanding shares of which 2.78 M shares are at this time shorted by private and institutional investors with about 4.21 trading days to cover. More on Repligen Cp
Follow Valuation Options Odds of Bankruptcy
Check how we calculate scores

Repligen Stock Highlights

Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. If you consider yourself one of those investors, make sure you clearly understand your entering position. Repligen's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Repligen or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
Repligen Cp generated a negative expected return over the last 90 days
Repligen Cp has high historical volatility and very poor performance
Repligen Cp is unlikely to experience financial distress in the next 2 years
Repligen Cp has a strong financial position based on the latest SEC filings
Over 88.0% of the company shares are owned by institutional investors
Latest headline from MacroaxisInsider: Acquisition by Anthony Hunt of 20307 shares of Repligen subject to Rule 16b-3
President CEO, DirectorAnthony Hunt
Average Analyst Recommendation
Analysts covering Repligen report their recommendations after researching Repligen's financial statements, talking to executives and customers, or listening in on Repligen's conference calls. The current trade recommendation is based on an ongoing consensus estimate among financial analysts covering Repligen Cp. The Repligen consensus assessment is calculated by taking the average forecast from all of the analysts covering Repligen.
Piotroski F Score
Piotroski F-Score is a popular financial indicator that puts together nine criteria to evaluate the financial strength of Repligen Cp based on its profitability, leverage, liquidity, source of funds, and operating efficiency. It is an academic score (developed by Joseph Piotroski in 2002) to determine the current strength of Repligen Cp financial position. Scores of 8 and 9 are usually classified as strong value stocks, whereas scores of 2 or below are considered weak value stocks.
 8 - StrongDetails
Current ValueLast YearChange From Last Year 10 Year Trend
Weighted Average Shares44.9 M55 M
Significantly Down
Slightly volatile
Weighted Average Shares Diluted46.4 M57.3 M
Significantly Down
Slightly volatile
Net Cash Flow from Operations128.4 M119 M
Significantly Up
Slightly volatile
Total Assets2.5 B2.4 B
Significantly Up
Slightly volatile
Total Liabilities656.3 M608.3 M
Significantly Up
Slightly volatile
Current AssetsB931.7 M
Significantly Up
Slightly volatile
Current Liabilities404.9 M375.3 M
Significantly Up
Slightly volatile
Total Debt85.2 M85.7 M
Slightly Down
Slightly volatile
Return on Average Assets6.536.0213
Significantly Up
Gross Margin65.7858.3496
Moderately Up
Slightly volatile
Asset Turnover0.40.3147
Significantly Up
Slightly volatile
Macroaxis Advice
Unlike general analyst consensus, Macroaxis buy hold or sell recommendation is provided in the context of your current investment horizon and risk tolerance. The advice algorithm takes into account all of Repligen's available fundamental, technical, and predictive indicators. Your current horizon is 90 days - details
Financial Strength
Repligen's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Repligen's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit.
Financial leverage usually refers to the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Repligen's financial leverage. It provides some insight into what part of Repligen's total assets is financed by creditors.
Share Download
Share Download
By using current balance sheet information, investors can analyze the liability, assets, and equity on Repligen's books and decide whether to invest or hold. Statistics such as return on equity (ROE), debt to equity (D/E) help investors determine how Repligen deploys its capital and how much of that capital is borrowed.
Repligen cash flow analysis is essential to understand how it generates and spends money over a specific period. It can also help you figure out where your money is going and how much cash you have available at a given moment. The company currently holds 393.58 M in liabilities with Debt to Equity (D/E) ratio of 0.22, which may suggest the company is not taking enough advantage from borrowing. Repligen Cp has a current ratio of 2.19, suggesting that it is liquid enough and is able to pay its financial obligations when due. Debt can assist Repligen until it has trouble settling it off, either with new capital or with free cash flow. So, Repligen's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Repligen Cp sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Repligen to invest in growth at high rates of return. When we think about Repligen's use of debt, we should always consider it together with cash and equity.

Operating Cash Flow

128.41 MillionShare
Repligen Cp (RGEN) is traded on NASDAQ Exchange in USA and employs 1,852 people. The company currently falls under 'Mid-Cap' category with current market capitalization of 9.21 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Repligen's market, we take the total number of its shares issued and multiply it by Repligen's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities. Repligen Cp conducts business under Healthcare sector and is part of Medical Instruments & Supplies industry. The entity has 55.29 M outstanding shares of which 2.78 M shares are at this time shorted by private and institutional investors with about 4.21 trading days to cover. Repligen Cp currently holds about 584.64 M in cash with 132.87 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 10.55.
Check Repligen Probability Of Bankruptcy
Repligen Cp has a total of 55.29 Million outstanding shares. The majority of Repligen Cp outstanding shares are owned by third-party entities. These institutional holders are usually referred to as non-private investors looking to secure positions in Repligen Cp to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Repligen. Please pay attention to any change in the institutional holdings of Repligen Cp as this could imply that something significant has changed or about to change at the company. Note that regardless of who owns the company, if the true value of the entity is less than the market is willing to pay for it, you may not be able to generate positive returns over time.

Ownership Allocation (%)

Check Repligen Ownership Details

Repligen Stock Price Odds Analysis

What are Repligen's target price odds to finish over the current price? Proceeding from a normal probability distribution, the odds of Repligen jumping above the current price in 90 days from now is about 25.72%. The Repligen Cp probability density function shows the probability of Repligen stock to fall within a particular range of prices over 90 days. Given the investment horizon of 90 days the stock has a beta coefficient of 1.5425 indicating as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Repligen will likely underperform. Additionally, the company has an alpha of 0.1911, implying that it can generate a 0.19 percent excess return over DOW after adjusting for the inherited market risk (beta).
  Odds Below 167.68HorizonTargetOdds Above 167.68
74.13%90 days
Based on a normal probability distribution, the odds of Repligen to move above the current price in 90 days from now is about 25.72 (This Repligen Cp probability density function shows the probability of Repligen Stock to fall within a particular range of prices over 90 days) .

Repligen Stock Institutional Holders

Institutional Holdings refers to the ownership stake in Repligen that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Repligen's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Repligen's value.
InstituionSecurity TypeTotal SharesValue
Blackrock IncCommon Shares5.4 MB
Vanguard Group IncCommon Shares4.9 M920.1 M
Aequim Alternative Investments LpDebt62.5 M107.8 M
View Repligen Diagnostics

Repligen Historical Income Statement

Repligen Cp Income Statement is one of the three primary financial statements used for reporting Repligen's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Repligen Cp revenue and expense. Repligen Income Statement primarily focuses on the company's revenues and expenses during a particular period.
Repligen Interest Expense is quite stable at the moment as compared to the past year. The company's current value of Interest Expense is estimated at 3.66 Million. Net Income is expected to rise to about 138.4 M this year, although the value of Weighted Average Shares will most likely fall to about 44.9 M. View More Fundamentals

Repligen Stock Against Markets

Picking the right benchmark for Repligen stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Repligen stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Repligen is critical whether you are bullish or bearish towards Repligen Cp at a given time.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Repligen without increasing your portfolio risk or giving up expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate.risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Financial Widgets Now


Financial Widgets

Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
All  Next Launch Module

Repligen Corporate Directors

Repligen corporate directors refer to members of a Repligen board of directors. The board of directors generally takes responsibility for the Repligen's affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Repligen's board members must vote for the resolution. The Repligen board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.
Thomas Ryan - Independent DirectorProfile
Glenn Muir - DirectorProfile
Alfred Goldberg - Independent DirectorProfile
Glenn Cooper - Independent DirectorProfile

Investing Repligen Cp

You need to understand the risk of investing before taking a position in Repligen. The danger of trading Repligen Cp is mainly related to its market volatility and company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Repligen is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Repligen. The Shape ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Repligen Cp is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Additionally, take a look at Your Equity Center. Note that the Repligen Cp information on this page should be used as a complementary analysis to other Repligen's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.

Complementary Tools for Repligen Stock analysis

When running Repligen Cp price analysis, check to measure Repligen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Repligen is operating at the current time. Most of Repligen's value examination focuses on studying past and present price action to predict the probability of Repligen's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Repligen's price. Additionally, you may evaluate how the addition of Repligen to your portfolios can decrease your overall portfolio volatility.
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Commodity Channel Index
Use Commodity Channel Index to analyze current equity momentum
Money Managers
Screen money managers from public funds and ETFs managed around the world
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Is Repligen's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Repligen. If investors know Repligen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Repligen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth YOY
Market Capitalization
9.2 B
Quarterly Revenue Growth YOY
Return On Assets
Return On Equity
The market value of Repligen Cp is measured differently than its book value, which is the value of Repligen that is recorded on the company's balance sheet. Investors also form their own opinion of Repligen's value that differs from its market value or its book value, called intrinsic value, which is Repligen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Repligen's market value can be influenced by many factors that don't directly affect Repligen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Repligen's value and its price as these two are different measures arrived at by different means. Investors typically determine Repligen value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Repligen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.